In this review, we will focus on the pathophysiologic role of IL-17A in three major systemic autoimmune diseases including systemic lupus erythematosus (SLE), Sjögren syndrome (SS), and systemic sclerosis (SSC). Here, IL17A is linked to systemic lupus erythematosus.